CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
Published on May 26, 2023
May 26, 2023
Via EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, DC 20549-3720
Attention: Conlon Danberg
Re: | Koru Medical Systems, Inc. Registration Statement on Form S-3 File No. 333-272026 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Koru Medical Systems, Inc. (the “Company”) hereby requests that the above-referenced Registration Statement on Form S-3 (File No. 333-272026) (the “Registration Statement”) be declared effective at 4:30 p.m. on Wednesday, May 31, 2023, or as soon thereafter as practicable. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Royer Cooper Cohen Braunfeld LLC, by calling Heather R. Badami at (484) 362-2632.
Sincerely,
Koru Medical Systems, Inc. |
|||
By: | /s/ Thomas Adams | ||
Thomas Adams | |||
Interim Chief Financial Officer |